SITE012-0006

SITE012 (BRA) › SITE012-0006

SITE012-0006

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2025-08-29

enrolled

AEs

6

Serious

1

Dropout signal

–

Adverse events

6

Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-08-05 (study day 154); relationship: not assessed

mild assessed

Grade 2 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-07-14 (study day 132); relationship: NOT RELATED

moderate assessed

Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-05-15 (study day 72); relationship: not assessed

mild assessed

Grade 3 Pneumonitis — outcome: RECOVERED/RESOLVED; onset 2022-04-12 (study day 39); relationship: not assessed; serious criteria: hospitalization

severe serious assessed

Grade 1 Pneumonitis — outcome: RECOVERED/RESOLVED; onset 2022-04-07 (study day 34); relationship: not assessed

mild assessed

Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-03-17 (study day 13); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.